OR WAIT null SECS
May 30, 2017
The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland.
May 25, 2017
This marks the first FDA approval of a treatment based on a specific biomarker.
May 24, 2017
The Competition and Market’s Authority is accusing Merck Sharp & Dohme of offering a discount for Remicade that may have restricted the sale of biosimilar competition in the UK.
May 22, 2017
The agency’s Committee for Medicinal Products for Human Use recommended AstraZeneca’s brodalumab for the treatment of moderate-to-severe plaque psoriasis.
Ablynx will receive EUR15 million in milestone payment following Merck’s decision to advance ALX-1141 into clinical development. The nanobody was developed by Ablynx under a 2011 collaboration between both parties.
Janssen filed a lawsuit in a US District Court in New Jersey against Samsung Bioepis, claiming the company’s new biosimilar infringed on its Remicade patents.
May 15, 2017
The company purchased Cirara from Remedy Pharmaceuticals for $120 million.
May 11, 2017
The companies entered a license agreement that includes Sangamo’s SB-525, one of the company’s lead product candidates for the treatment of Hemophilia A.
May 09, 2017
Licensing agreement will expand Oxford Genetics bio-therapeutic discovery, design, and development service business.
May 05, 2017
Novartis entered separate license agreements with bluebird bio and Celyad for patents related to the manufacture of CAR-T cells.